Capricorn Fund Managers LTD Genmab A/S Transaction History

Capricorn Fund Managers LTD

  • $122 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 11, 2023
BUY
$35.27 - $42.24 $1.31 Million - $1.56 Million
37,007 New
37,007 $1.31 Million
Q1 2023

Apr 18, 2023
BUY
$34.88 - $43.22 $3.86 Million - $4.78 Million
110,643 New
110,643 $4.18 Million
Q3 2022

Nov 09, 2022
SELL
$31.52 - $373.61 $4.31 Million - $51.1 Million
-136,643 Reduced 92.07%
11,768 $378,000
Q2 2022

Aug 10, 2022
BUY
$26.83 - $38.57 $3.98 Million - $5.72 Million
148,411 New
148,411 $4.82 Million

Others Institutions Holding GMAB

# of Institutions
236
Shares Held
52.5M
Call Options Held
10.2K
Put Options Held
25.5K
View Full List

About GENMAB A/S

GMAB Quotes by TradingView
  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.6B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Capricorn Fund Managers LTD Portfolio

Follow Capricorn Fund Managers LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capricorn Fund Managers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capricorn Fund Managers LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email